ENVERIC BIOSCIENCES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.938 USD | +6.35% |
|
+3.04% | -27.85% |
| Mar. 26 | Enveric Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 19 | Sector Update: Health Care Stocks Rise Late Afternoon | MT |
Chart calendar Enveric Biosciences, Inc.
0bf644757e6787f04276.kzquJgIpvR6Ju1bmtDmJ8aUzm6sk9kTmo3TJoW1Z0Xk.9lPIX1VbjnH88zKtgFrbhvBp_cEJrzys7xyGzzRhsBfHT5YXa0qMSbrtFw~7454f68b80111e17e3dbc5c86de8783e
Upcoming events on Enveric Biosciences, Inc.
Past events on Enveric Biosciences, Inc.
| 2024-03-27 | Q4 2023 Earnings Release (Projected) |
| 2024-01-07 | Biotech Showcase |
| 2023-11-13 04:01 pm | Q3 2023 Earnings Release |
| 2023-11-02 10:00 am | Annual General Meeting |
| 2023-10-31 | Canadian Chemical Engineering Conference - Dr. Jillian Hagel |
| 2023-10-29 | Canadian Chemical Engineering Conference |
| 2023-10-25 02:10 pm | Centurion One Global Summit |
| 2023-10-09 | Neuropsychiatric Drug Development Summit |
| 2023-09-17 | Molecular Biology and Biochemistry International Conference |
| 2023-09-11 07:00 am | H.C. Wainwright Global Investment Conference |
| 2023-08-14 08:00 am | Q2 2023 Earnings Release |
| 2023-06-26 07:00 am | H.C. Wainwright Neuropsychiatry Virtual Conference |
| 2023-06-04 | BIO International Convention |
| 2023-05-27 | Canadian Neuroscience Annual Meeting |
| 2023-05-15 09:25 am | Q1 2023 Earnings Release |
| 2023-04-03 04:05 pm | Q4 2022 Earnings Release |
| 2023-03-02 05:00 pm | Gravitas Securities Growth Conference |
| 2023-03-02 04:40 pm | Gravitas Securities Growth Conference - Panel |
| 2023-02-06 03:00 pm | BIO CEO and Investor Conference |
| 2023-01-10 01:00 pm | Biotech Showcase |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | -14,8 -14,8 0.21% | -13,7 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -25,9 -17,7 -46.68% | -20,0 -20,7 3.65% | -16,4 -18,6 11.46% | -16,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -56,4 -10,9 -417.01% | 0,00 0,00 - | -17,3 -18,0 4.16% | -18,0 |
|
Net income Million USD | Released Forecast Spread | -6,86 | -49,0 -10,9 -349.23% | -18,5 -17,9 -3.35% | -17,5 -18,1 3.62% | -18,0 |
|
EPS USD | Released Forecast Spread | -59,5 | -104 -25,5 -305.88% | -13,0 -12,5 -4.33% | -8,09 -8,17 0.98% | -2,08 |
| Announcement Date | 01/04/21 | 31/03/22 | 31/03/23 | 26/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | ||||
|
EBIT Million USD | Released Forecast Spread | -12,3 -4,04 -204.22% | -4,80 -3,69 -29.93% | -4,71 -4,79 1.65% | -5,66 -5,08 -11.27% | -4,80 -5,80 17.21% | -5,67 -1,50 -277.9% | -3,45 -4,75 27.4% | -2,38 -3,70 35.56% | ||||||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -49,6 -4,04 -1125.83% | -4,52 -3,69 -22.57% | -2,87 -4,82 40.42% | -2,48 -4,92 49.6% | -3,41 -3,40 -0.4% | |||||||||
|
Net income Million USD | Released Forecast Spread | -42,1 -4,03 -944.67% | -4,52 -3,91 -15.59% | -2,87 -4,82 40.42% | -2,60 -4,92 47.08% | -4,68 | -3,44 -3,40 -1.06% | ||||||||
|
EPS USD | Released Forecast Spread | -86,5 -8,00 -981.25% | -5,50 -6,00 8.33% | -2,73 -4,50 39.33% | -1,46 -4,50 67.56% | -2,31 | -1,30 -1,93 32.64% | -1,47 -1,55 4.85% | -0,61 | -0,55 | -0,52 | -0,40 | -0,40 | ||
| Announcement Date | 31/03/22 | 13/05/22 | 12/08/22 | 14/11/22 | 31/03/23 | 15/05/23 | 11/08/23 | 13/11/23 | 26/03/24 | - | - | - | - | - |
More events
Past sector events for Enveric Biosciences, Inc.
| 2024-04-17 | HINOVA PHARMACEUTICALS INC.: Q4 2023 Earnings Release |
| 2024-04-17 02:07 am | TELIX PHARMACEUTICALS LIMITED: March 2024 Sales and Revenue Release - Activities Report |
| 2024-04-10 04:10 pm | PHARVARIS N.V.: Q4 2023 Earnings Release |
| 2024-04-10 01:22 am | POLARIS GROUP: March 2024 Sales and Revenue Release |
| 2024-04-02 02:30 am | ABIVAX: Q4 2023 Earnings Release |
| 2024-04-01 09:00 am | BIOMEA FUSION, INC.: Q4 2023 Earnings Release |
| 2024-03-28 10:42 pm | ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release |
| 2024-03-28 04:28 pm | CENTESSA PHARMACEUTICALS PLC: Q4 2023 Earnings Release |
| 2024-03-28 04:05 pm | ARRIVENT BIOPHARMA, INC.: Q4 2023 Earnings Release |
| 2024-03-28 07:10 am | HANGZHOU TIGERMED CONSULTING CO., LTD: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ENVB Stock
- Calendar Enveric Biosciences, Inc.
